Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 20Recruiting 9Terminated 7Unknown 6Withdrawn 4Not yet recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Lymphoid 1

Conditions

Colorectal Neoplasms 296Carcinoma, Hepatocellular 213Stomach Neoplasms 155Pancreatic Neoplasms 155Rectal Neoplasms 114Esophageal Neoplasms 84Colonic Neoplasms 78Esophageal Squamous Cell Carcinoma 52Cholangiocarcinoma 48Liver Neoplasms 47Biliary Tract Neoplasms 36Neoplasms 31Breast Neoplasms 31Neoplasm Metastasis 28Carcinoma, Non-Small-Cell Lung 27Gastrointestinal Neoplasms 26Lung Neoplasms 20Disease 18Prostatic Neoplasms 17Uterine Cervical Neoplasms 16Recurrence 16Ovarian Neoplasms 14Colorectal Neoplasms, Hereditary Nonpolyposis 13Endometrial Neoplasms 12Head and Neck Neoplasms 11Adenocarcinoma Of Esophagus 11Gallbladder Neoplasms 10Colonic Polyps 10Anus Neoplasms 10Melanoma 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Cachexia × Gastrointestinal × Clear all
NCT07565415 2026-05-04

Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy

Nanfang Hospital, Southern Medical University

Phase 2 Not yet recruiting
88 enrolled
Gastrointestinal

Anorexia, Cachexia, Carcinoma, Hepatocellular, Malnutrition

NCT07356037 2026-01-21

Nanocrystalline Megestrol Acetate for Cachectic Stage Locally Advanced Hepatocellular Carcinoma

Changchun GeneScience Pharmaceutical Co., Ltd.

Phase 3 Not yet recruiting
68 enrolled
Gastrointestinal

Cachexia, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡